• BridgeBio's Navire preps SHP2 blocker for lung cancer trial after positive mouse study

    11 days ago - By Fierce Biotech

    BridgeBio's Navire preps SHP2 blocker for lung cancer trial after positive mouse study arlene.weintraub
    Mon, 09/14/2020 - 07:59
    Read more ...